These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15063912)

  • 1. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy.
    King AC; Canada SA
    J Subst Abuse Treat; 2004 Apr; 26(3):189-95. PubMed ID: 15063912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England.
    Beynon CM; Bellis MA; McVeigh J
    BMC Public Health; 2006 Aug; 6():205. PubMed ID: 16904004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying pregnant women at risk for early attrition from substance abuse treatment.
    Kissin WB; Svikis DS; Moylan P; Haug NA; Stitzer ML
    J Subst Abuse Treat; 2004 Jul; 27(1):31-8. PubMed ID: 15223091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Client-reported reasons for non-engagement in drug and alcohol treatment.
    Coulson C; Ng F; Geertsema M; Dodd S; Berk M
    Drug Alcohol Rev; 2009 Jul; 28(4):372-8. PubMed ID: 19594791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
    McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
    Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders.
    McKellar J; Kelly J; Harris A; Moos R
    Addict Behav; 2006 Mar; 31(3):450-60. PubMed ID: 15979244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No-shows, drop-outs and completers in psychotherapeutic treatment: demographic and clinical predictors in a large sample of non-psychotic patients.
    Fenger M; Mortensen EL; Poulsen S; Lau M
    Nord J Psychiatry; 2011 Jun; 65(3):183-91. PubMed ID: 20854221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day hospital and residential addiction treatment: randomized and nonrandomized managed care clients.
    Witbrodt J; Bond J; Kaskutas LA; Weisner C; Jaeger G; Pating D; Moore C
    J Consult Clin Psychol; 2007 Dec; 75(6):947-59. PubMed ID: 18085911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
    Satre DD; Mertens JR; Areán PA; Weisner C
    Addiction; 2004 Oct; 99(10):1286-97. PubMed ID: 15369567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility.
    Daughters SB; Lejuez CW; Bornovalova MA; Kahler CW; Strong DR; Brown RA
    J Abnorm Psychol; 2005 Nov; 114(4):729-34. PubMed ID: 16351393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency and causes of premature termination (drop-out) during in-patient opiate detoxification].
    Gössling HW; Gunkel S; Schneider U; Melles W
    Fortschr Neurol Psychiatr; 2001 Oct; 69(10):474-81. PubMed ID: 11602924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drop-out from clinical psychotherapeutic treatment of personality problems].
    Cornelissen AT; Poppe E; Ouwens MA
    Tijdschr Psychiatr; 2010; 52(1):17-27. PubMed ID: 20054794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of drop-out in overweight and obese outpatients.
    Inelmen EM; Toffanello ED; Enzi G; Gasparini G; Miotto F; Sergi G; Busetto L
    Int J Obes (Lond); 2005 Jan; 29(1):122-8. PubMed ID: 15545976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.